Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 107, Issue 2, 2003, Pages 81-86

  Tsuboi, Y ^a,d   Kakimoto, K ^b   Nakajima, M ^a   Akatsu, H ^c   Yamamoto, T ^c   Ogawa, K ^a   Ohnishi, T ^b   Daikuhara, Y ^b   Yamada, Tatsuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Astrocyte; Cerebrospinal fluid; Enzyme linked immunosorbent assay; Hepatocyte growth factor; Magnetic resonance imaging; White matter damage

Indexed keywords

SCATTER FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0037291698     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.02089.x     Document Type: Review

References (33)

1. MATSUMOTO K, NAKAMURA T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996;119:591-600.
2. TAMURA M, DAIKUHARA Y. Structure and function of hepatocyte growth factor/scatter factor (HGF/SF). Curr Topics Biochem Res 2000;2:150-7.
3. TASHIRO K, HAGIYA M, NISHIZAWA T et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci 1990;87:3200-4.
4. JUNG W, CASTERN E, ODENTHAL M et al. Expression and functional interaction of hepatocyte growth factor - scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994;126:485-94.
5. YAMAGATA T, MUROYA K, MUKASA T et al. Hepatocyte growth factor specifically expressed in microglia activated ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun 1995;210:231-7.
6. BOTTARO DP, RUBIN JS, FALETTO DL, CHAN AM-L, KMIECIK TE, VAN DE WOUNDE GF. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
7. NALDINI L, VIGNA E, NARSIMHAN RP et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene 1991;6:501-4.
8. NALDINI L, WEIDNER KM, VIGNA E et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991;10:2867-78.
9. MIYAZAWA K, SHIMOMURA T, KITAMURA A, KONDO J, MORIMOTO Y, KITAMURA N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993;268:10024-8.
10. SHIMOMURA T, MIYAZAWA K, KOMIYAMA Y et al. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995;229:257-61.
11. MARS WM, ZARNEGAR R, MICHALOPOULOS GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-58.
12. NALDI L, VIGNA E, BARDELLI A, FOLLENZI A, GALIMI F, COMOGLIO PM. Biological activation of pro-HGF by urokinase is controlled by a stoichiometric reaction. J Biol Chem 1995;270:603-11.
13. SHIMOMURA T, KONDO J, OCHIAI M et al. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 1993;268:22927-32.
14. KAWAGUCHI T, QIN L, SHIMOMURA T et al. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 1997;272:27558-64.
15. SHIMOMURA T, DENDA K, KITAMURA A et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997;272:6370-6.
16. ITOH H, KATAOKA H, HAMASUNA R, KITAMURA N, KOONO M. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine protease inhibitor domain is a predominant product in mouse but not in human. Biochem Biophysic Res Commun 1999;255:740-8.
17. FENTON H, FINCH PW, RUBIN JS et al. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res 1998;779:262-70.
18. HONDA S, KAGOSHIMA M, WANAKA A, TOHYAMA M, MATSUMOTO K, NAKAMURA T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Mol Brain Res 1995;32:197-210.
19. YAMADA T, TSUBOUCHI H, DAIKUHARA Y et al. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 1994;637:308-12.
20. YAMADA T, YOSHIYAMA Y, TSUBOI Y, SHIMOMURA T. Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues. Brain Res 1997;762:251-5.
21. YAMADA T, TSUJIOKA Y, TAGUCHI J, TAKAHASHI M, TSUBOI Y, SHIMOMURA T. White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues. Exp Neurol 1998;153:60-4.
22. TSUBOI Y, KAKIMOTO K, AKATSU H, DAIKUHARA Y, YAMADA T. Hepatocyte growth factor in cerebrospinal fluid in neurologic disease. Acta Neurol Scand 2002;106:99-103.
23. TIBBLING G, LINK H, OHMAN S. Principles of albumin and 1gG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
24. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: reports of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-44.
25. TSUBOUCHI H, NIITANI Y, HIRONO S et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991;13:1-5.
26. OHNISHI T, KAKIMOTO K, HASHIDA S et al. Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects. J Immunol Meth 2000;244:163-73.
27. YOSHIYAMA Y, ARAKAKI N, NAKA D et al. Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem Biophys Res Commun 1991;175:660-7.
28. TOMIMOTO H, AKIGUCHI I, AKIYAMA H et al. Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol 1999;97:629-34.
29. WALLIN A. The overlap between Alzheimer's disease and vascular dementia: the role of white matter changes. Dement Geriatr Cogn Disord 1998;9(Suppl. 1):30-5.
30. LEYS D, PRUVO JP, PARENT M et al. Could Wallerian degeneration contribute to 'leuko-araiosis' in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 1991;54:46-50.
31. BRUN A, ENGLUND E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-62.
32. FAZEKA F, SCHMIDT R, SCHELTENS P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998;9(Suppl. 1):2-5.
33. LATERRA J, NAM M, ROSEN E, RAO JS, JOHNSTON P. Scatter factor/hepatocyte growth factor gene transfer to 9L glioma cells enhances glioma growth and angiogenesis in vivo. Laboratory Invest 1997;76:565-77.